Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.81M | 1.07M | 2.13M | 293.00K | 886.00K |
| Total Receivables | 709.00K | 2.05M | 2.80M | 2.62M | 2.07M |
| Inventory | 1.59M | 1.91M | 1.56M | 1.21M | 1.31M |
| Prepaid Expenses | 592.00K | 656.00K | 901.00K | 346.00K | 525.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 305.00K | 310.00K | 359.00K | 315.00K | 220.00K |
| Total Current Assets | 6.00M | 6.00M | 7.75M | 4.79M | 5.02M |
|
|
|||||
| Total Current Assets | 6.00M | 6.00M | 7.75M | 4.79M | 5.02M |
| Net Property, Plant & Equipment | 894.00K | 834.00K | 879.00K | 927.00K | 973.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 202.00K | 203.00K | 207.00K | 167.00K | 168.00K |
| Total Assets | 16.37M | 18.70M | 21.44M | 20.76M | 23.34M |
|
|
|||||
| Total Accounts Payable | 208.00K | 215.00K | 282.00K | 724.00K | 750.00K |
| Total Accrued Expenses | 26.56M | 27.47M | 25.52M | 24.54M | 21.62M |
| Short-term Debt | 26.58M | 28.01M | 11.15M | 10.77M | 11.40M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 390.00K | 349.00K | 17.73M | 17.15M | 17.15M |
| Total Finance Division Other Current Liabilities | 12.38M | 14.49M | 14.39M | 10.99M | 11.15M |
| Total Other Current Liabilities | 12.38M | 14.49M | 14.39M | 10.99M | 11.15M |
| Total Current Liabilities | 66.12M | 70.54M | 69.07M | 64.17M | 62.08M |
|
|
|||||
| Total Current Liabilities | 66.12M | 70.54M | 69.07M | 64.17M | 62.08M |
| Long-Term Debt | 2.25M | 2.28M | 2.27M | 2.26M | 2.26M |
| Short-term Debt | 26.58M | 28.01M | 11.15M | 10.77M | 11.40M |
| Capital Leases | 1.30M | 1.32M | 1.41M | 1.50M | 1.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.88M | 12.42M | 12.29M | 12.31M | 13.13M |
| Total Liabilities | 82.55M | 86.56M | 85.04M | 80.24M | 79.05M |
|
|
|||||
| Common Stock & APIC | 226.06M | 226.06M | 226.06M | 225.98M | 225.97M |
| Retained Earnings | -272.06M | -273.40M | -270.07M | -268.12M | -266.04M |
| Treasury Stock & Other | -20.17M | -20.52M | -19.60M | -17.35M | -15.63M |
| Total Common Equity | -66.18M | -67.86M | -63.61M | -59.49M | -55.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -66.18M | -67.86M | -63.61M | -59.49M | -55.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -66.18M | -67.86M | -63.61M | -59.49M | -55.70M |
|
|
|||||